Keep Me Logged In
Leonard Schleifer, Regeneron president & CEO, discusses the FDA's approval of its cholesterol-lowering drug Praluent, and concerns over pricing the new drug. With Jeffrey Sonnenfeld, Yale School of Management.
Got a confidential news tip? We want to hear from you.
Sign up for free newsletters and get more CNBC delivered to your inbox
© 2018 CNBC LLC. All Rights Reserved. A Division of NBCUniversal
Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes, and Market Data and Analysis.
Data also provided by